Research Technician - Islet Transplant Research Group, University of Oxford

Update on somatropin-containing medicines (European Medicines Agency press release, 16 December 2010)

Sutent (sunitinib) receives European approval for a new indication in progressive pancreatic neuroendocrine tumours (NET) (Medical News Today, 16 December 2010)

16 Dec 2010

The European Commission has approved Pfizer's Sutent (sunitinib malate) for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (NET) with disease progression in adults.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read